Monometal-doped nanozymes ameliorate rheumatoid arthritis by regulating neutrophil ferroptosis via the MDM2–P53–SLC7A11 pathway
Source abstract
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent joint inflammation and swelling. Neutrophils play pivotal roles in the pathogenesis of RA and represent potential therapeutic targets. In this study, we investigated the efficacy of monometal-doped nanozymes (MDNs)on the RA murine model and the therapeutic mechanisms. Our results demonstrated that these MDNs effectively inhibit the formation of neutrophil extracellular traps (NETs) and suppress inflammatory responses. Furthermore, the MDNs induce ferroptosis in neutrophils by regulating the MDM2-P53-solute carrier family 7 member 11 (SLC7A11) signaling pathway. Collectively, these findings suggest that MDNs may serve as a promising therapeutic strategy for RA by modulating the ferroptosis-NETosis balance in neutrophils via the MDM2-p53-SLC7A11 axis.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Neutrophil, Myeloperoxidase and Oxidative Mechanisms · Immune cells in cancer · Ferroptosis and cancer prognosis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (45)
Show source-provided references
1. Origins of rheumatoid arthritis10.1016/j.jbspin.2019.11.009 ↗
2. What is rheumatoid arthritis?10.1001/jama.2022.0786 ↗
3. Global, regional and national burden of rheumatoid arthritis from 1990 to 2021, with projections of incidence to 2050: a systematic and comprehensive analysis of the global burden of disease study 202110.1186/s40364-025-00760-8 ↗
4. Pharmacotherapy options in rheumatoid arthritis10.4137/CMAMD.S5558 ↗
5. Overview of rheumatoid arthritis and scientific understanding of the disease10.31138/mjr.20230801.oo ↗
6. The new water-soluble artemisinin derivative SM905 ameliorates collagen-induced arthritis by suppression of inflammatory and Th17 responses10.1038/bjp.2008.11 ↗
7. Treatment strategies in early rheumatoid arthritis and prevention of rheumatoid arthritis10.1007/s11926-012-0275-1 ↗
8. Prevention and treatment of rheumatoid arthritis through traditional Chinese medicine: role of the gut microbiota10.3389/fimmu.2023.1233994 ↗
9. Neutrophil extracellular trap-associated carbamylation and histones trigger osteoclast formation in rheumatoid arthritis10.1136/ard-2022-223568 ↗
10. Ferroptosis and autoimmune diseases10.3389/fimmu.2022.916664 ↗
11. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications10.1016/j.cell.2022.06.003 ↗
12. Application of glutathione depletion in cancer therapy: enhanced ROS-Based therapy, ferroptosis, and chemotherapy10.1016/j.biomaterials.2021.121110 ↗
13. Lophatherum-gracile driven near-infrared carbon dots inhibit ferroptosis and mitophagy to treat acute kidney injury
14. pH-sensitive molybdenum (Mo)-based polyoxometalate nanoclusters have therapeutic efficacy in inflammatory bowel disease by counteracting ferroptosis10.1016/j.phrs.2023.106645 ↗
15. Orally administrated liquid metal agents for inflammation-targeted alleviation of inflammatory bowel diseases10.1126/sciadv.adn1745 ↗
16. Immunomodulatory metal-based biomaterials for cancer immunotherapy10.1016/j.jconrel.2024.09.008 ↗
17. Phosphorylation of NIR‐II emitting Au nanoclusters for targeted bone imaging and improved rheumatoid arthritis therapy10.1002/agt2.435 ↗
18. Functionalized Fe-Doped carbon dots exhibiting dual glutathione consumption to amplify ferroptosis for enhanced cancer therapy10.1021/acsami.3c12356 ↗
19. Ce6-modified Fe ions-doped carbon dots as multifunctional nanoplatform for ferroptosis and photodynamic synergistic therapy of melanoma10.1186/s12951-024-02346-2 ↗
20. Metal ions-doped carbon dots: synthesis, properties, and applications10.1016/j.cej.2021.133101 ↗
21. Sulfasalazine promotes ferroptosis through AKT-ERK1/2 and P53-SLC7A11 in rheumatoid arthritis10.1007/s10787-024-01439-6 ↗
22. Role of nanoparticle size, shape and surface chemistry in oral drug delivery10.1016/j.jconrel.2016.07.051 ↗
23. Size-dependent absorption mechanism of polymeric nanoparticles for oral delivery of protein drugs10.1016/j.biomaterials.2012.07.063 ↗
24. Surface-modified CeO2 coating with excellent thermal shock resistance performance and low infrared emissivity at high-temperature10.1016/j.surfcoat.2018.10.058 ↗
25. Preparation and characterization of a greenish yellow lackluster coating with low infrared emissivity based on Prussian blue modified aluminum10.1016/j.porgcoat.2014.04.003 ↗
26. Neutrophil extracellular traps: potential targets for the treatment of rheumatoid arthritis with traditional Chinese medicine and natural products10.1002/ptr.8311 ↗
27. A review of neutrophil extracellular traps (NETs) in disease: potential Anti-NETs therapeutics10.1007/s12016-020-08804-7 ↗
28. Emerging insights into the role of ferroptosis in the pathogenesis of autoimmune diseases10.3389/fimmu.2023.1120519 ↗
29. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles10.1038/nnano.2007.260 ↗
30. Natural medicines-derived carbon dots as novel oral antioxidant administration strategy for ulcerative colitis therapy10.1186/s12951-024-02702-2 ↗
31. What potential do magnetic iron oxide nanoparticles have for the treatment of rheumatoid arthritis?10.2217/nnm-2019-0071 ↗
32. Carbon dots supported single Fe atom nanozyme for drug-resistant glioblastoma therapy by activating autophagy-lysosome pathway10.1016/j.nantod.2022.101530 ↗
33. Amorphous silica coatings on magnetic nanoparticles enhance stability and reduce toxicity to in vitro BEAS-2B cells10.3109/08958378.2011.592869 ↗
34. Potential toxicity of iron oxide magnetic nanoparticles: a review10.3390/molecules25143159 ↗
35. In situ formation of ferrous sulfide in glycyrrhizic acid hydrogels to promote healing of multi-drug resistant staphylococcus aureus-infected diabetic wounds10.1016/j.jcis.2023.07.141 ↗
36. Berberine synergises with ferroptosis inducer sensitizing NSCLC to ferroptosis in p53-dependent SLC7A11-GPX4 pathway
37. Modulating hydrothermal condition to achieve carbon dots-zeolite composites with multicolor afterglow10.1007/s12274-023-5410-y ↗
38. The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks10.7150/ijbs.83348 ↗
39. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer10.1016/j.redox.2022.102317 ↗
40. Autophagosomes defeat ferroptosis by decreasing generation and increasing discharge of free Fe(2+) in skin repair cells to accelerate diabetic wound healing
41. Ferroptosis: machinery and regulation10.1080/15548627.2020.1810918 ↗
42. Ferroptosis in rheumatoid arthritis: a potential therapeutic strategy
43. MDM2 and MDMX promote ferroptosis by PPARα-mediated lipid remodeling10.1101/gad.334219.119 ↗
44. STAT6 inhibits ferroptosis and alleviates acute lung injury via regulating P53/SLC7A11 pathway10.1038/s41419-022-04971-x ↗
45. The secretome derived from 3D-cultured umbilical cord tissue MSCs counteracts manifestations typifying rheumatoid arthritis10.3389/fimmu.2019.00018 ↗